Literature DB >> 20020427

Conversion of ancestral fibroblasts to induced pluripotent stem cells.

Ryoko Araki1, Yuko Jincho, Yuko Hoki, Miki Nakamura, Chihiro Tamura, Shunsuke Ando, Yasuji Kasama, Masumi Abe.   

Abstract

The emergence of induced pluripotent stem cells (iPSCs) from an ancestral somatic cell is one of the most important processes underlying their generation, but the mechanism has yet to be identified. This is principally because these cells emerge at a low frequency, about 0.1% in the case of fibroblasts, and in a stochastic manner. In our current study, we succeeded in identifying ancestral fibroblasts and the subsequent processes leading to their conversion to iPSCs. The ancestral fibroblasts were found to divide several times in a morphologically symmetric manner, maintaining a fibroblastic shape, and then gradually transform into embryonic stem-like cells. Interestingly, this conversion occurred within 48 hours after gene introduction in most iPSC generations. This is the first report to directly observe a cell lineage conversion of somatic cells to stem cells and provides a critical new insight into the "black box" of iPSCs, that is, the first three days of their generation.

Mesh:

Year:  2010        PMID: 20020427     DOI: 10.1002/stem.282

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

Review 1.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

Review 2.  Molecular features of cellular reprogramming and development.

Authors:  Zachary D Smith; Camille Sindhu; Alexander Meissner
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-17       Impact factor: 94.444

Review 3.  Cell signalling pathways underlying induced pluripotent stem cell reprogramming.

Authors:  Kate Hawkins; Shona Joy; Tristan McKay
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 4.  Induced pluripotent stem cells: opportunities and challenges.

Authors:  Keisuke Okita; Shinya Yamanaka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

5.  Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.

Authors:  Jong Soo Kim; Hyun Woo Choi; Sol Choi; Han Geuk Seo; Sung-Hwan Moon; Hyung-Min Chung; Jeong Tae Do
Journal:  Stem Cells Dev       Date:  2014-08-20       Impact factor: 3.272

6.  Low- and High-LET Ionizing Radiation Induces Delayed Homologous Recombination that Persists for Two Weeks before Resolving.

Authors:  Christopher P Allen; Hirokazu Hirakawa; Nakako Izumi Nakajima; Sophia Moore; Jingyi Nie; Neelam Sharma; Mayumi Sugiura; Yuko Hoki; Ryoko Araki; Masumi Abe; Ryuichi Okayasu; Akira Fujimori; Jac A Nickoloff
Journal:  Radiat Res       Date:  2017-05-23       Impact factor: 2.841

7.  Human amniotic epithelial cells are reprogrammed more efficiently by induced pluripotency than adult fibroblasts.

Authors:  Charles A Easley; Toshio Miki; Carlos A Castro; John A Ozolek; Crescenzio F Minervini; Ahmi Ben-Yehudah; Gerald P Schatten
Journal:  Cell Reprogram       Date:  2012-06       Impact factor: 1.987

Review 8.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

9.  Dynamic migration and cell-cell interactions of early reprogramming revealed by high-resolution time-lapse imaging.

Authors:  Cynthia M Megyola; Yuan Gao; Alexandra M Teixeira; Jijun Cheng; Kartoosh Heydari; Ee-Chun Cheng; Timothy Nottoli; Diane S Krause; Jun Lu; Shangqin Guo
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

Review 10.  Mechanisms and models of somatic cell reprogramming.

Authors:  Yosef Buganim; Dina A Faddah; Rudolf Jaenisch
Journal:  Nat Rev Genet       Date:  2013-06       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.